Us Congress 2025-2026 Regular Session

Us Congress House Bill HR175 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	IV
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. RES. 175
5	5	Recognizing the seriousness of polycystic ovary syndrome (PCOS) and ex-
6	6	pressing support for the designation of the month of September as
7	7	‘‘PCOS Awareness Month’’.
8	8	IN THE HOUSE OF REPRESENTATIVES
9	9	FEBRUARY27, 2025
10	10	Mr. D
11	11	AVIDSCOTTof Georgia (for himself, Mr. FITZPATRICK, Ms.
12	12	W
13	13	ASSERMANSCHULTZ, Ms. SCHAKOWSKY, Mr. BACON, Ms. BARRAGA´N,
14	14	Mr. B
15	15	OYLEof Pennsylvania, Mrs. CHERFILUS-MCCORMICK, Ms. CHU,
16	16	Mr. C
17	17	OHEN, Mrs. WATSONCOLEMAN, Mr. CONNOLLY, Ms. OCASIO-COR-
18	18	TEZ, Ms. DEANof Pennsylvania, Ms. DELBENE, Mr. FOSTER, Mrs.
19	19	H
20	20	AYES, Mr. JOHNSONof Georgia, Mr. LARSONof Connecticut, Ms.
21	21	M
22	22	CBRIDE, Ms. MCCOLLUM, Mrs. MCIVER, Ms. MENG, Ms. MOOREof
23	23	Wisconsin, Mr. M
24	24	ULLIN, Ms. NORTON, Mr. POCAN, Ms. STANSBURY, Ms.
25	25	S
26	26	EWELL, Ms. TITUS, Ms. VELA´ZQUEZ, Ms. CLARKEof New York, and
27	27	Mr. T
28	28	ONKO) submitted the following resolution; which was referred to the
29	29	Committee on Energy and Commerce
30	30	RESOLUTION
31	31	Recognizing the seriousness of polycystic ovary syndrome
32	32	(PCOS) and expressing support for the designation of
33	33	the month of September as ‘‘PCOS Awareness Month’’.
34	34	Whereas polycystic ovary syndrome (PCOS) is a common
35	35	health problem among women and girls involving a hor-
36	36	monal imbalance;
37	37	Whereas there is no universal definition of PCOS, but re-
38	38	searchers estimate that 5,000,000 to 10,000,000 women
39	39	VerDate Sep 11 2014 23:12 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR175.IH HR175
40	40	ssavage on LAPJG3WLY3PROD with BILLS 2
41	41	•HRES 175 IH
42	42	in the United States are affected by the condition, and
43	43	prevalence estimates range from 8 to 13 percent of
44	44	women globally;
45	45	Whereas the most recent published data, a 2004 study, esti-
46	46	mates the annual burden of PCOS in the United States
47	47	is $4,360,000,000, and this figure pertains to women’s
48	48	reproductive years alone and does not consider the cost
49	49	of other comorbidities, including obstetrical complications
50	50	or the cost of metabolic morbidities in post-menopause or
51	51	adolescence;
52	52	Whereas PCOS can affect girls from the onset of puberty and
53	53	throughout the remainder of their lives;
54	54	Whereas the symptoms of PCOS include infertility, irregular
55	55	or absent menstrual periods, acne, weight gain, thinning
56	56	of scalp hair, excessive facial and body hair growth, nu-
57	57	merous small ovarian cysts, pelvic pain, and mental
58	58	health problems;
59	59	Whereas women with PCOS have higher rates of psychosocial
60	60	disorders, including depression, anxiety, bipolar disorder,
61	61	and eating disorders, and are at greater risk for suicide;
62	62	Whereas adolescents with PCOS often are not diagnosed,
63	63	many of whom have metabolic dysfunction and insulin re-
64	64	sistance, which can lead to type 2 diabetes, cardio-
65	65	vascular disease, obstructive sleep apnea, nonalcoholic
66	66	fatty liver disease, and endometrial cancer at a young
67	67	adult age;
68	68	Whereas PCOS is the most common cause of female infer-
69	69	tility;
70	70	Whereas PCOS in pregnancy is associated with increased risk
71	71	of gestational diabetes, preeclampsia, pregnancy-induced
72	72	VerDate Sep 11 2014 23:12 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6300 E:\BILLS\HR175.IH HR175
73	73	ssavage on LAPJG3WLY3PROD with BILLS 3
74	74	•HRES 175 IH
75	75	hypertension, preterm delivery, cesarean delivery, mis-
76	76	carriage, and fetal and infant death;
77	77	Whereas women with PCOS are at increased risk of devel-
78	78	oping high blood pressure, high cholesterol, stroke, and
79	79	heart disease (the leading cause of death among women);
80	80	Whereas women with PCOS have a more than 50 percent
81	81	chance of developing type 2 diabetes or prediabetes be-
82	82	fore the age of 40;
83	83	Whereas women with PCOS may be at a higher risk for
84	84	breast cancer and ovarian cancer, and have a 3 times
85	85	higher risk for developing endometrial cancer compared
86	86	to women who do not have PCOS;
87	87	Whereas research has found genetic evidence of a causal link
88	88	to depression in PCOS;
89	89	Whereas research has found genetic correlations with obesity,
90	90	fasting insulin, type 2 diabetes, lipid levels, and coronary
91	91	artery disease, indicating shared genetic architecture be-
92	92	tween metabolic traits and PCOS;
93	93	Whereas adolescents with PCOS are at markedly increased
94	94	risk for type 2 diabetes, fatty liver disease, and heart dis-
95	95	ease;
96	96	Whereas PCOS negatively alters metabolic function inde-
97	97	pendent of, but exacerbated by, increased BMI;
98	98	Whereas an estimated 50 percent of women with PCOS are
99	99	undiagnosed, and many remain undiagnosed until they
100	100	experience fertility difficulties or develop type 2 diabetes
101	101	or other cardiometabolic disorders;
102	102	Whereas the cause of PCOS is unknown, but researchers
103	103	have found strong links to a genetic predisposition, and
104	104	VerDate Sep 11 2014 23:12 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6300 E:\BILLS\HR175.IH HR175
105	105	ssavage on LAPJG3WLY3PROD with BILLS 4
106	106	•HRES 175 IH
107	107	significant insulin resistance, which affects up to 70 per-
108	108	cent of women with PCOS; and
109	109	Whereas there is no known cure for PCOS: Now, therefore,
110	110	be it
111	111	Resolved, That the House of Representatives— 1
112	112	(1) recognizes polycystic ovary syndrome 2
113	113	(PCOS) as a serious disorder that impacts many as-3
114	114	pects of health, including cardiometabolic, reproduc-4
115	115	tive, and mental health as well as quality of life; 5
116	116	(2) supports the goals and ideals of PCOS 6
117	117	Awareness Month, which are to— 7
118	118	(A) increase awareness of, and education 8
119	119	about, PCOS and its connection to 9
120	120	comorbidities such as type 2 diabetes, 10
121	121	endometrial cancer, cardiovascular disease, non-11
122	122	alcoholic fatty liver disease, and mental health 12
123	123	disorders among the general public, women, 13
124	124	girls, and health care professionals; 14
125	125	(B) improve diagnosis and treatment of 15
126	126	the disorder; 16
127	127	(C) disseminate information on PCOS di-17
128	128	agnosis, treatment, and management including 18
129	129	prevention of comorbidities such as type 2 dia-19
130	130	betes, endometrial cancer, cardiovascular dis-20
131	131	ease, nonalcoholic fatty liver disease, and eating 21
132	132	disorders; and 22
133	133	VerDate Sep 11 2014 23:12 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\HR175.IH HR175
134	134	ssavage on LAPJG3WLY3PROD with BILLS 5
135	135	•HRES 175 IH
136	136	(D) improve quality of life and outcomes 1
137	137	for women and girls with PCOS; 2
138	138	(3) recognizes the need for further research, 3
139	139	improved treatment and care options, and a cure for 4
140	140	PCOS; 5
141	141	(4) acknowledges the struggles affecting all 6
142	142	women and girls afflicted with PCOS residing within 7
143	143	the United States; 8
144	144	(5) urges medical researchers and health care 9
145	145	professionals to advance their understanding of 10
146	146	PCOS in order to research, diagnose, and provide 11
147	147	assistance to women and girls with PCOS; and 12
148	148	(6) encourages States, territories, and localities 13
149	149	to support the goals and ideals of PCOS Awareness 14
150	150	Month. 15
151	151	Æ
152	152	VerDate Sep 11 2014 23:12 Feb 27, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6301 E:\BILLS\HR175.IH HR175
153	153	ssavage on LAPJG3WLY3PROD with BILLS